Wales Patient Access Scheme: Process Guidance - AWMSG

Wales Patient Access Scheme: Process Guidance July 2012 (Updated August 2016) This Guidance document has been prepared by the Patient Access Scheme Wales Group, with support from the All Wales Therapeutics and Toxicology Centre (AWTTC), and has subsequently been endorsed by the All Wales Medicines Strategy Group ( AWMSG ). Please direct any queries to AWTTC: All Wales Therapeutics and Toxicology Centre University Hospital Llandough Penlan Road Llandough Vale of Glamorgan CF64 2XX 029 2071 6900 This document should be cited as: All Wales Medicines Strategy Group, Wales Patient Access Scheme: Process Guidance . August 2016. Wales Patient Access Scheme: Process Guidance Page 1 of 33 ABBREVIATIONS ABPI Association of the British Pharmaceutical Industry AWDCC All Wales Drug Contracting Committee AWMSG All Wales Medicines Strategy Group AWTTC All Wales Therapeutics and Toxicology Centre FAR Final Appraisal Report HTA Health Technology Assessment NICE National Institute for Health and Care Excellence PAS Patient Access Scheme PASLU Patient Access Scheme Liaison Unit PASWG Patient Access Scheme Wales Group PPRS Pharmaceutical Price Regulation Scheme WPAS Wales Patient Access Scheme ACKNOWLEDGEMENTS The All Wales Medicines Strategy Group would like to acknowledge the Welsh Government, the Therapeutic Development Asses

This guidance document has been prepared by the Patient Access Scheme Wales Group, with support from the All Wales Therapeutics and Toxicology Centre (AWTTC),

Loading..

Tags:

  Patients, Access, Wales, Patient access, Wales patient access

Information

Related search queries